274 related articles for article (PubMed ID: 20012434)
21. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
22. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D
Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367
[TBL] [Abstract][Full Text] [Related]
23. [The clinical manifestations of histologically classified malignant lymphomas in the ENT area].
Zwirner P; Grevers G; Wilmes E
Laryngorhinootologie; 1990 Dec; 69(12):642-6. PubMed ID: 2288627
[TBL] [Abstract][Full Text] [Related]
24. Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia.
Peh SC; Kim LH; Thanaletchimy N; Chai SP; Poppema S
Malays J Pathol; 2000 Jun; 22(1):13-20. PubMed ID: 16329532
[TBL] [Abstract][Full Text] [Related]
25. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
26. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
Reiter A; Tiemann M; Ludwig WD; Wacker HH; Yakisan E; Schrappe M; Henzler D; Sykora KW; Brandt A; Odenwald E
Klin Padiatr; 1994; 206(4):222-33. PubMed ID: 7967418
[TBL] [Abstract][Full Text] [Related]
27. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
29. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
31. Extranodal malignant lymphoma of the upperaerodigestive tract in King Chulalongkorn Memorial Hospital according to WHO classification.
Assanasen T; Wannakrairot P; Keelawat S; Pramprayoon N; Chaipipat M
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S249-54. PubMed ID: 16083197
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
33. Extranodal primary tumor site indicates poor prognosis in childhood head and neck non-Hodgkin's lymphomas.
Ribeiro RC; Fairclough DL; Sandlund JT; Crist WM; Berard CW; Pui CH
Leukemia; 1991 Jul; 5(7):615-20. PubMed ID: 2072748
[TBL] [Abstract][Full Text] [Related]
34. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
[TBL] [Abstract][Full Text] [Related]
35. [Incidence and histologic patterns of bone marrow involvement of malignant lymphoma based on the World Health Organization classification: a single institution study].
Jeong SY; Chang YH; Lee JK; Hong YJ; Hong SI; Lee SS
Korean J Lab Med; 2007 Dec; 27(6):383-7. PubMed ID: 18160826
[TBL] [Abstract][Full Text] [Related]
36. [Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].
Wang JF; Wang YZ; Chen ZW; Taylor RC
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):218-23. PubMed ID: 16776979
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification.
Sukpanichnant S
Hum Pathol; 2004 Feb; 35(2):224-30. PubMed ID: 14991541
[TBL] [Abstract][Full Text] [Related]
38. Eight-year experience of malignant lymphoma--survival and prognostic factors.
Hahn JS; Lee S; Chong SY; Min YH; Ko YW
Yonsei Med J; 1997 Oct; 38(5):270-84. PubMed ID: 9409190
[TBL] [Abstract][Full Text] [Related]
39. Extranodal lymphoma: a comparative study.
AlShemmari SH; Ameen RM; Sajnani KP
Hematology; 2008 Jun; 13(3):163-9. PubMed ID: 18702874
[TBL] [Abstract][Full Text] [Related]
40. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]